For a biotech world often focused on oncology and gene editing, Hemab Therapeutics has carved out a very different frontier: rare, inherited bleeding disorders that have long gone overlooked. The company has raised $157 million in a Series C round, a multifold oversubscribed financing led by Sofinnova Partners, with participation from a global sovereign wealth…
In the quiet corridors of interventional radiology, change is seldom dramatic — but sometimes it’s seismic. That may be the case for Polyembo, the Longmont-Colorado based medical-device startup, which has just closed a fresh round of funding led by a multinational strategic investor. The proceeds are earmarked for advancing its next‐generation vascular embolic systems, including…
In Naples, Florida, medical-technology company Catalyst OrthoScience Inc. announced a fresh injection of $15 million in equity and debt financing, led by RC Capital and joined by Mutual Capital Partners, physician-entrepreneur board member Dr. Derace Schaffer, and Western Alliance Bank. The move underscores growing investor confidence in the company’s mission to streamline shoulder replacement surgery with fewer…
In a landmark moment for ad-tech, San Francisco-based startup AdsGency has secured $12 million in seed funding, led by XYZ Venture Capital, with participation from Streamlined Ventures, HF0 and Hat‑Trick Capital. Founded in 2023, AdsGency is setting out to become the industry’s first agentic ad agency, automating the full performance-marketing workflow using large-language-model powered agents….
When Streetbeat began its journey three years ago, the idea of a machine parsing market movements, client emotions, and portfolio risk simultaneously sounded ambitious—even indulgent. But today, the Palo Alto–based startup is reshaping what advisory work looks like in financial institutions. And investors are taking notice. The company has raised $15 million in a Series…
In an era where cross-border payments are often slow, costly, and riddled with inefficiencies, Cybrid, a fintech startup based in Newark, New Jersey, is positioning itself as a game-changer. The company has successfully raised $10 million in a Series A funding round, led by BDC Capital’s Growth Venture Fund, with additional backing from Golden Ventures,…
In a landscape crowded with large language models (LLMs) that demand enormous computational resources, MythWorx is charting a radically different course. The Dallas-based startup closed a $5 million seed round at a striking $100 million valuation—an unusually high mark for early-stage AI ventures—underscoring investor belief in its disruptive approach to artificial general intelligence (AGI). Spearheaded…
In the evolving landscape of entertainment, where the boundaries between gaming, narrative, and technology blur, Wolf Games emerges as a pioneering force reshaping how stories are told and experienced. The Los Angeles-based generative entertainment startup recently secured $9 million in a Series A funding round led by Main Street Advisors, signaling a strong vote of…
In the evolving landscape of defense technology, Safe Pro Group Inc. [NASDAQ: SPAI] is staking a decisive claim. The Florida-based company, under CEO and Chairman Dan Erdberg, recently closed a $14 million strategic funding round led by Ondas Holdings Inc. [NASDAQ: ONDS], marking a significant step toward expanding its AI-powered drone image processing capabilities amid…
In a significant capital infusion, Summit Therapeutics Inc., a Miami-headquartered biopharmaceutical company specializing in oncology, has successfully raised $500 million through a private placement of approximately 26.68 million common shares priced at $18.74 each—the closing price on October 21, 2025. The offering was led by a blend of institutional biotech investors and company insiders, signaling…
